ML277

CAS No. 1401242-74-7

ML277( CID-53347902 )

Catalog No. M23558 CAS No. 1401242-74-7

ML277 was identified as a potent activator of KCNQ1 channels (EC(50)=260 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 77 In Stock
5MG 67 In Stock
10MG 112 In Stock
25MG 202 In Stock
50MG 299 In Stock
100MG 449 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ML277
  • Note
    Research use only, not for human use.
  • Brief Description
    ML277 was identified as a potent activator of KCNQ1 channels (EC(50)=260 nM).
  • Description
    ML277 was identified as a potent activator of KCNQ1 channels (EC(50)=260 nM).
  • In Vitro
    ML277 (1 μM) increases the amplitude of KCNQ1 whole-cell and single-channel currents.
  • In Vivo
    ——
  • Synonyms
    CID-53347902
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    KCNQ1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1401242-74-7
  • Formula Weight
    471.6
  • Molecular Formula
    C23H25N3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:≥60 mg/mL (127.23mM)
  • SMILES
    O=C([C@@H]1N(S(=O)(C2=CC=C(C)C=C2)=O)CCCC1)NC3=NC(C4=CC=C(OC)C=C4)=CS3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mattmann ME, Yu H, Lin Z, et al. Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator. Bioorg Med Chem Lett. 2012;22(18):5936-5941. doi:10.1016/j.bmcl.2012.07.060
molnova catalog
related products
  • BMS-813160

    BMS-813160 is the first dual?CCR2/CCR5?antagonist to enter Clinical development for cardiovascular.

  • Rabeprazole

    Rabeprazole (LY307640) is an H+/K+-ATPase inhibitor that inhibits cell proliferation in gastric epithelial cells by targeting STAT3-mediated glycolysis and can be used in the study of gastric ulcers.

  • RU-TRAAK-2

    RU-TRAAK-2 is a reversible inhibitor of TWIK-related arachidonic acid-stimulated K+ channel with no activity for non-K2P channels including Kv1.2, GIRK2, and Slo1.